LCM
SCPH

Laurion Capital Management’s scPharmaceuticals SCPH Stock Holding History

Laurion Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,873
Closed -$263K – 616
2023
Q4 		$263K Sell
41,873
-106,942
-72% -$612K ﹤0.01% 419
2023
Q3 		$1.06M Sell
148,815
-16,185
-10% -$128K 0.01% 365
2023
Q2 		$1.68M Hold
165,000
– – 0.01% 324
2023
Q1 		$1.5M Hold
165,000
– – 0.01% 288
2022
Q4 		$1.18M Buy
+165,000
New +$1.01M 0.01% 321

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Laurion Capital Management's SCPH Position: Q1 2024 in Review

Laurion Capital Management sold out of scPharmaceuticals (SCPH) in Q1 2024, closing a stake of 41,873 shares — an estimated $263K sold.

Laurion Capital Management first reported a position in SCPH in Q4 2022 and held it in 5 quarters. The position peaked at $1.68M in Q2 2023. 76 funds tracked by Wall St. Rank hold SCPH as of Q1 2024.

  • Laurion Capital Management reported no remaining scPharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Laurion Capital Management sold 41,873 scPharmaceuticals shares in Q1 2024, an estimated $263K.
  • Laurion Capital Management first reported a position in scPharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Laurion Capital Management's scPharmaceuticals position peaked at $1.68M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held scPharmaceuticals as of Q1 2024.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.